SEC Form 4 · accession 0001209191-16-089793
AMICUS THERAPEUTICS, INC. · FOLD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jay Barth
Officer — Chief Medical Officer
Period of report
Dec 3, 2015
Accepted (ET)
Jan 6, 2016 · 4:12 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001178879
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Dec 3, 2015 | M | 25,000 | — | A | 40,687 | D | |
| Common stock | Dec 3, 2015 | F | 9,313 | $10.05 | D | 31,374 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted stock unitsF1,F2 | — | Dec 3, 2015 | M | 25,000 | D | — | — | Common Stock | 25,000 | 0 | D |
| Stock Options (right to buy)F3 | $9.03 | Jan 4, 2016 | A | 90,000 | A | — | Jan 4, 2026 | Common Stock | 90,000 | 90,000 | D |
Explanation of responses
- F1Restricted stock units convert into common stock on a one-for-one basis.
- F2On April 10, 2014, the reporting person was granted 50,000 restricted stock units, vesting in equal installments of 25,000 restricted stock units on May 10, 2015 and 25,000 restricted stock units on December 3, 2015.
- F3These options vest and become exercisable in a series of installments. The first installment, which consists of 25% of the total aggregate number of options granted, vests on January 4, 2017. The remaining options vest and become exercisable in a series of thirty-five successive equal monthly installments, beginning on February 1, 2017, with the final installment vesting on January 1, 2020.